RBI
SRPT icon

Raiffeisen Bank International’s Sarepta Therapeutics SRPT Stock Holding History

Raiffeisen Bank International’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Hold
1,465
– – ﹤0.01% 648
2026
Q1 		$31.9K Hold
1,465
– – ﹤0.01% 600
2025
Q4 		$26.5K Hold
1,465
– – ﹤0.01% 601
2025
Q3 		$28.2K Buy
+1,465
New +$26.1K ﹤0.01% 592

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Raiffeisen Bank International's SRPT Position: Q2 2026 in Review

Raiffeisen Bank International increased its Sarepta Therapeutics (SRPT) stake by 9.6% in Q2 2026, buying an estimated $94.6K and bringing the position to 57,000 shares worth $970K. The position accounts for 0.01% of the portfolio, ranked #418.

Raiffeisen Bank International first reported a position in SRPT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2025. 134 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Raiffeisen Bank International held 57,000 shares of Sarepta Therapeutics worth $970K as of Q2 2026.
  • Raiffeisen Bank International bought 5,000 Sarepta Therapeutics shares in Q2 2026, an estimated $94.6K.
  • Sarepta Therapeutics made up 0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #418 holding.
  • Raiffeisen Bank International first reported a position in Sarepta Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Sarepta Therapeutics position peaked at $1.22M in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.